Robert Henry, MD

Professor of Medicine Division of Endocrinology & Metabolism, University of California San Diego Chief, Section of Diabetes, Endocrinology and Metabolism Director, Center for Metabolic Research VA San Diego Healthcare System

Robert R. Henry, MD, is Professor of Medicine in the Division of Endocrinology & Metabolism at the University of California, San Diego. He is also Chief of both the Section of Endocrinology, Metabolism & Diabetes and the Center for Metabolic Research at the VA Medical Center in San Diego.

Dr Henry received his medical degree from the University of Manitoba Medical School, Manitoba, Canada, where he also completed his residency in internal medicine and fellowship in endocrinology.

He is Past President of the American Diabetes Association Medicine and Science (2011) and is a member of the American Association of Clinical Endocrinology, the European Association for the Study of Diabetes, the Obesity Society, the Endocrine Society, Western Society for Clinical Investigation, Western Association of Physicians, the American Federation for Clinical Research and the Royal College of Physicians Edinburgh. His research is funded by the National Institutes of Health-NIDDK, the American Diabetes Association, the Department of Veterans Affairs and numerous pharmaceutical grants. Recent awards include the Distinguished Clinical Scientist Award from the American Diabetes Association, the Mary Jane Kugal Award of the Juvenile Diabetes Research Foundation International, the Robert H. Williams-Rachmiel Levine Award from the Western Metabolism Club, Frontiers in Science Award from American Association of Clinical Endocrinology and the Banting Medal for Public Service from the American Diabetes Association.

Dr Henry has published more than 350 journal articles and chapters. His current clinical research interests involve the study of new therapies for type 1 and type 2 diabetes and obesity. Basic science interests include study of the metabolic and cardiovascular effects of human skeletal muscle and adipose tissue secretory products including adiponectin, signal interactions between skeletal muscle and adipose tissue and defects of insulin signal transduction in these tissues of obese and type 2 diabetic patients.